• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine.

作者信息

Kessler Alaina J, Para Andrew, Niedt George W, Klein Paula

机构信息

Division of Hematology and Medical Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

出版信息

JAAD Case Rep. 2023 Mar 8;35:122-125. doi: 10.1016/j.jdcr.2023.02.016. eCollection 2023 May.

DOI:10.1016/j.jdcr.2023.02.016
PMID:37188285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10176165/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa7/10176165/504a630052ff/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa7/10176165/0cb4ab5554b2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa7/10176165/504a630052ff/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa7/10176165/0cb4ab5554b2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa7/10176165/504a630052ff/gr2.jpg

相似文献

1
Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine.接受辅助性卡培他滨治疗的三阴性乳腺癌患者出现抗转录中介因子-1γ抗体阳性皮肌炎。
JAAD Case Rep. 2023 Mar 8;35:122-125. doi: 10.1016/j.jdcr.2023.02.016. eCollection 2023 May.
2
Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.以抗TIF-1γ抗体为首发症状的皮肌炎作为三阴性乳腺癌的潜在表现：一例报告
BMC Cancer. 2016 Aug 25;16(1):684. doi: 10.1186/s12885-016-2715-1.
3
Small cell lung cancer and interstitial pneumonia associated with anti-transcriptional intermediary factor-1γ-positive dermatomyositis.小细胞肺癌与抗转录中介因子-1γ阳性皮肌炎相关的间质性肺炎。
Respirol Case Rep. 2019 Mar 12;7(4):e00412. doi: 10.1002/rcr2.412. eCollection 2019 May.
4
Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy.与恶性肿瘤相关的抗TIF-1γ抗体阳性皮肌炎的临床特征
J Clin Med. 2022 Mar 30;11(7):1925. doi: 10.3390/jcm11071925.
5
Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis.抗转录中介因子-1γ 自身抗体在识别伴癌成人皮肌炎患者中的应用：系统评价和荟萃分析。
Acta Derm Venereol. 2019 Mar 1;99(3):256-262. doi: 10.2340/00015555-3091.
6
Clinical features of anti-transcription intermediary factor 1γ (TIF1γ)-positive dermatomyositis with internal malignancy and investigation of the involvement of TIF1γ expression in tumors in the pathogenesis of cancer-associated dermatomyositis.抗转录中介因子1γ（TIF1γ）阳性皮肌炎伴发内脏恶性肿瘤的临床特征及TIF1γ表达在肿瘤中的参与情况对癌相关性皮肌炎发病机制的研究
J Dermatol. 2020 Dec;47(12):1395-1402. doi: 10.1111/1346-8138.15526. Epub 2020 Jul 30.
7
Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis.病例报告：抗转录中介因子-1γ 抗体阳性皮肌炎患者的 IgA 肾病。
Front Immunol. 2022 Feb 3;13:757802. doi: 10.3389/fimmu.2022.757802. eCollection 2022.
8
Triple carcinomas detected in two patients with anti-transcription intermediary factor 1γ (TIF1γ) antibody-positive dermatomyositis.
Eur J Dermatol. 2022 Apr 1;32(2):285-287. doi: 10.1684/ejd.2022.4232.
9
Small Cell Lung Cancer Patient with Anti-transcriptional Intermediary Factor 1γ Antibody Who Developed Dermatomyositis after Successful Chemoradiotherapy.小细胞肺癌患者在放化疗成功后出现皮肌炎，伴有抗转录中介因子1γ抗体。
Intern Med. 2019 Feb 1;58(3):427-431. doi: 10.2169/internalmedicine.1007-18. Epub 2018 Sep 12.
10
Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.大多数癌症相关性皮肌炎患者体内存在针对核基质蛋白NXP - 2或转录中介因子1γ的抗体。
Arthritis Rheum. 2013 Nov;65(11):2954-62. doi: 10.1002/art.38093.

引用本文的文献

1
Association Between Anti-TIF1-γ Antibody and Triple-Negative Breast Carcinoma in Dermatomyositis Patients: A Case Report.皮肌炎患者抗TIF1-γ抗体与三阴性乳腺癌之间的关联：一例报告
Clin Case Rep. 2025 Feb 10;13(2):e70157. doi: 10.1002/ccr3.70157. eCollection 2025 Feb.

本文引用的文献

1
A case of capecitabine-induced dermatomyositis.一例卡培他滨诱发的皮肌炎病例。
Indian J Pharmacol. 2018 Nov-Dec;50(6):350-353. doi: 10.4103/ijp.IJP_356_18.
2
Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis.抗转录中介因子-1γ 自身抗体在识别伴癌成人皮肌炎患者中的应用：系统评价和荟萃分析。
Acta Derm Venereol. 2019 Mar 1;99(3):256-262. doi: 10.2340/00015555-3091.
3
Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.
特发性炎性肌病相关肌炎特异性自身抗体的临床和病理表型。
Curr Rheumatol Rep. 2018 Apr 10;20(5):28. doi: 10.1007/s11926-018-0733-5.
4
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.卡培他滨辅助治疗新辅助化疗后的乳腺癌。
N Engl J Med. 2017 Jun 1;376(22):2147-2159. doi: 10.1056/NEJMoa1612645.
5
Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.以抗TIF-1γ抗体为首发症状的皮肌炎作为三阴性乳腺癌的潜在表现：一例报告
BMC Cancer. 2016 Aug 25;16(1):684. doi: 10.1186/s12885-016-2715-1.
6
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.成人皮肌炎中与抗转录中介因子-1γ抗体相关的独特皮肤和全身特征。
J Am Acad Dermatol. 2015 Mar;72(3):449-55. doi: 10.1016/j.jaad.2014.12.009. Epub 2015 Jan 14.
7
Dermatomyositis associated with capecitabine in the setting of malignancy.在恶性肿瘤背景下与卡培他滨相关的皮肌炎。
J Am Acad Dermatol. 2014 Feb;70(2):e47-8. doi: 10.1016/j.jaad.2013.10.025.
8
Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.肌炎特异性抗155/140自身抗体靶向转录中介因子1家族蛋白。
Arthritis Rheum. 2012 Feb;64(2):513-22. doi: 10.1002/art.33403.
9
Therapy of polymyositis and dermatomyositis.多发性肌炎和皮肌炎的治疗。
Autoimmun Rev. 2011 Nov;11(1):6-13. doi: 10.1016/j.autrev.2011.06.007. Epub 2011 Jun 28.
10
Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.静脉注射免疫球蛋白治疗类固醇激素抵抗性皮肌炎/多发性肌炎相关食管受累：73 例患者系列研究。
Arthritis Care Res (Hoboken). 2010 Dec;62(12):1748-55. doi: 10.1002/acr.20325.